Result of AGM

RNS Number : 1370C
Dechra Pharmaceuticals PLC
06 November 2009
 










Date: 6 November 2009


Dechra® Pharmaceuticals PLC

(the "Company" or the "Group")

Results of Annual General Meeting ("AGM")



Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 6 November 2009 were duly passed on a show of hands.


Copies of the following: 



  • Ordinary resolution relating to the renewal of the authority for the directors to allot new shares;


  • Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights;


  • Special resolution relating to the renewal of the authority for the Company to purchase its own shares;


  • Special resolution relating to the calling of any general meeting of the Company (other than an AGM) on not less than 14 clear days notice; and 


  • Special resolution relating to the deletion of the current memorandum of Association and  adoption of new Articles of Association,


being resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM on 6 November 2009will be submitted to the UK Listing Authority and will thereafter be available for publication at the UK Listing Authority's Document Viewing Facility which is situated at :


    Financial Services Authority

    25 The North Colonnade

    Canary Wharf

    London E14 5HS


    Tel : 020 7066 1000

  

Details of the proxy voting instructions lodged prior to the AGM are set out below:


Resolution (No. as noted on proxy form)


For

Against

Discretionary

Withheld

Resolution 1:

To receive and consider report and accounts


48,564,546

29,100

108,998

120,000



Resolution 2:

To receive and approve the Directors Remuneration Report


44,705,769

35,807

108,998

3,972,070

Resolution 3:

To declare a final dividend


48,593,646

0

108,998

120,000

Resolution 4:

To re-elect Simon Evans


47,543,459

1,049,699

108,998

120,488

Resolution 5:

To re-elect Malcolm Diamond


47,152,727

1,402,148

108,998

158,771

Resolution 6:

To re-appoint KPMG Audit plc as Auditors 


47,912,195

6,187

783,774

120,488

Resolution 7:

To authorise the Directors to fix the Auditors Remuneration


47,911,328

4,638

783,407

123,271

Resolution 8:

To grant authority to allot equity securities


47,298,926

38,138

112,331

1,373,249

Resolution 9:

To renew authority for pre-emptive allotment of equity securities


48,582,856

5,134

112,331

122,323

Resolution 10:

To grant authority to the Company to purchase


48,583,581

6,732

112,331

120,000

Resolution 11:

 To call general meetings (other than an AGM) on not less than 14 clear days notice


48,079,695

510,260

112,689

120,000

Resolution 12:

To delete the existing memorandum of Association and adopt New Articles of Association


47,681,002

538,040

112,456

491,146



Enquiries:



Zoe Goulding, Company Secretary

Dechra Pharmaceuticals PLC

Tel: +44 (0) 1782 771100



Dechra and the Dechra 'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEALFKEAXNFFE
UK 100

Latest directors dealings